H3K27me3 levels are determined by histone methyltransferase EZH2 (enhancer of zeste homolog 2) and histone demethylase JMJD3 (jumonji domain-containing 3), and both these proteins are upregulated in prostate cancer [10]. This evidence concerns the gene EZH2 and prostate cancer.